Gyre Therapeutics Inc. Net Asset Quality Index
Gyre Therapeutics Inc. net asset quality index. Gyre Therapeutics Inc. (GYRE) has a Net Asset Quality Index of 84.6% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $162.01 Million minus total liabilities of $25.03 Million yields net assets of $136.99 Million. A higher index indicates a stronger, lower-leverage balance sheet. See Gyre Therapeutics Inc. (GYRE) shareholders funds for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Gyre Therapeutics Inc. (2002–2025)
Net asset quality index of Gyre Therapeutics Inc. from 2002 to 2025. This chart shows how Gyre Therapeutics Inc.'s Net Asset Quality Index has evolved across 24 annual periods from 2002 to 2025. As of March 2026, the index stands at 84.6%, representing net assets of $136.99 Million against total assets of $162.01 Million USD. Check Gyre Therapeutics Inc. strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Gyre Therapeutics Inc. Net Asset Quality Index by Year (2002–2025)
Gyre Therapeutics Inc. net asset quality index by year from 2002 to 2025. The table below presents the year-by-year Net Asset Quality Index for Gyre Therapeutics Inc. from 2002 to 2025, covering 24 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Gyre Therapeutics Inc. market capitalisation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 85.6% | $142.28 Million | $166.13 Million | $23.85 Million | ▲ +7.2 pp |
| 2024 | 78.5% | $98.40 Million | $125.41 Million | $27.00 Million | ▲ +66.5 pp |
| 2023 | 12.0% | $13.95 Million | $116.54 Million | $102.59 Million | ▼ -73.2 pp |
| 2022 | 85.2% | $72.22 Million | $84.75 Million | $12.54 Million | ▲ +11.4 pp |
| 2021 | 73.8% | $41.09 Million | $55.66 Million | $14.57 Million | ▼ -6.4 pp |
| 2020 | 80.2% | $76.07 Million | $94.85 Million | $18.78 Million | ▲ +10.9 pp |
| 2019 | 69.3% | $68.34 Million | $98.55 Million | $30.22 Million | ▼ -26.7 pp |
| 2018 | 96.0% | $119.94 Million | $124.92 Million | $4.97 Million | ▲ +18.1 pp |
| 2017 | 77.9% | $30.77 Million | $39.51 Million | $8.74 Million | ▲ +35.7 pp |
| 2016 | 42.2% | $16.07 Million | $38.09 Million | $22.02 Million | ▼ -3.0 pp |
| 2015 | 45.2% | $31.43 Million | $69.52 Million | $38.10 Million | ▼ -52.2 pp |
| 2014 | 97.4% | $109.08 Million | $112.00 Million | $2.91 Million | ▲ +5.1 pp |
| 2013 | 92.3% | $134.61 Million | $145.87 Million | $11.26 Million | ▼ -0.5 pp |
| 2012 | 92.8% | $175.91 Million | $189.58 Million | $13.66 Million | ▲ +25.3 pp |
| 2011 | 67.5% | $174.29 Million | $258.13 Million | $83.84 Million | ▲ +32.6 pp |
| 2010 | 35.0% | $91.85 Million | $262.79 Million | $170.94 Million | ▲ +13.3 pp |
| 2009 | 21.6% | $68.99 Million | $319.38 Million | $250.39 Million | ▼ -36.6 pp |
| 2008 | 58.2% | $57.37 Million | $98.55 Million | $41.18 Million | ▲ +6.1 pp |
| 2007 | 52.1% | $51.58 Million | $98.96 Million | $47.38 Million | ▼ -27.8 pp |
| 2006 | 79.9% | $65.00 Million | $81.37 Million | $16.37 Million | ▲ +660.1 pp |
| 2005 | -580.3% | $-162.48 Million | $28.00 Million | $190.48 Million | ▼ -369.0 pp |
| 2004 | -211.3% | $-122.97 Million | $58.20 Million | $181.17 Million | ▼ -308.2 pp |
| 2003 | 96.9% | $45.93 Million | $47.39 Million | $1.46 Million | ▲ +0.8 pp |
| 2002 | 96.2% | $52.29 Million | $54.38 Million | $2.09 Million | — |